Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on June 16, 2026

Jun. 16, 2026

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Indeterminate GlobeNewswire

Jun. 16, 2026

Swvl Announces Q1 2026 Results; Revenue Up 68%; GCC Revenue Up 111%; Dollar-Pegged Revenue Up 111% and Net Dollar Retention of 114%

Indeterminate GlobeNewswire

Jun. 16, 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Indeterminate GlobeNewswire

Jun. 16, 2026

King Faisal Specialist Hospital Presents Robotic Surgery as a Model for Innovation-Driven Specialized Care at HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 die Roboterchirurgie als Vorbild für innovationsgetriebene Spezialversorgung

Indeterminate GlobeNewswire

Jun. 16, 2026

Le King Faisal Specialist Hospital présente la chirurgie robotique comme modèle de soins spécialisés axés sur l’innovation lors du congrès HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Indeterminate GlobeNewswire

Jun. 16, 2026

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

Indeterminate GlobeNewswire

Jun. 16, 2026

Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting

Indeterminate GlobeNewswire

Jun. 16, 2026

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial

Indeterminate GlobeNewswire

Jun. 16, 2026

Nexxen Raises Full-Year 2026 Contribution ex-TAC and Programmatic Revenue Guidance for the Second Time This Year Ahead of Today’s Investor Day

Indeterminate GlobeNewswire

Jun. 16, 2026

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease

Indeterminate GlobeNewswire

Jun. 16, 2026

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Indeterminate GlobeNewswire

Jun. 16, 2026

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

Indeterminate GlobeNewswire

Jun. 16, 2026

NexGold Mining Signs Memorandum of Understanding with Eagle Lake First Nation and Lac Seul First Nation on Goliath Gold Complex

Indeterminate GlobeNewswire

Jun. 16, 2026

Allot to Participate at the Roth Conference in London on June 17 & 18, 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Newcore Gold Drilling Intersects 1.37 g/t Gold over 24.0 Metres, Including 1.93 g/t Gold over 12.0 Metres, at the Enchi Gold Project, Ghana

Indeterminate GlobeNewswire

Jun. 16, 2026

AI-Driven Revenue Optimisation Delivers Nearly $600 Million in Additional Profit for Travel Companies, Mize Data Reveals

Indeterminate GlobeNewswire

Jun. 16, 2026

King Faisal Specialist Hospital Showcases Applied AI Ecosystem in Radiology at HLTH Europe 2026

Indeterminate GlobeNewswire